Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
726 questions in 98 reviews · Pregnancy and Childbirth
current versionsNo studies 726 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Magnesium sulphate vs placebo (outcomes Breastfeeding at hospital discharge** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulphate vs placebo (outcomes Women’s views of treatment** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Vitamin B12 supplementation vs placebo/no vitamin B12 supplementation Neural tube defects ‐ not reported · pregnant women Vitamin B12 supplementation during pregnancy for maternal and child health outcomes (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Any psychosocial intervention vs treatment Adverse events ‐ not measured · stopping or reducing alcohol consumption during pregnancy Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Any psychosocial intervention vs treatment Withdrawal signs and symptoms ‐ not measured · stopping or reducing alcohol consumption during pregnancy Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy (2024) · Cochrane | no estimate extracted | NR | No studies |
Respiratory syncytial virus vaccine vs placebo Infant hospitalisation with clinically confirmed RSV disease · pregnant woman Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Planned hospital birth vs Planned home birth Maternal mortality ‐ not reported · Pregnant women at low risk of complications Planned hospital birth compared with planned home birth for pregnant women at low risk of complications (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Planned hospital birth vs Planned home birth Perinatal mortality ‐ not reported · Pregnant women at low risk of complications Planned hospital birth compared with planned home birth for pregnant women at low risk of complications (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Planned hospital birth vs Planned home birth Apgar < 7 at 5 min ‐ not reported · Pregnant women at low risk of complications Planned hospital birth compared with planned home birth for pregnant women at low risk of complications (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Planned hospital birth vs Planned home birth Transfer to neonatal intensive care unit ‐ not reported · Pregnant women at low risk of complications Planned hospital birth compared with planned home birth for pregnant women at low risk of complications (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Planned hospital birth vs Planned home birth Maternal satisfaction ‐ not reported · Pregnant women at low risk of complications Planned hospital birth compared with planned home birth for pregnant women at low risk of complications (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Premature rupture of membranes ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Use of oxytocin ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Cord blood pH < 7.1 ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Need for ECV ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: lower‐dose regimens vs standard‐dose regimens Other neonatal morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Severe morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Side effects · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Other neonatal morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Severe morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Death of the baby before discharge from hospital · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Maternal death · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Other neonatal morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Severe morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Side effects · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Side effects · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Other neonatal morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Severe morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Side effects · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Death of the baby before discharge from hospital · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Maternal death · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Other neonatal morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: short vs standard maintenance regimen (subgroups by type of short regimen) Death of the baby before discharge from hospital · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: short vs standard maintenance regimen (subgroups by type of short regimen) Maternal death · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: short vs standard maintenance regimen (subgroups by type of short regimen) Other neonatal morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: higher vs lower IV maintenance regimen Severe morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: higher vs lower IV maintenance regimen Death of the baby before discharge from hospital · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: higher vs lower IV maintenance regimen Maternal death · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: higher vs lower IV maintenance regimen Other neonatal morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: maintenance regimen by continuous infusion vs a serial IV bolus regimen Severe morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Other neonatal morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: lower‐dose regimens vs standard‐dose regimens Side effects · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Intensity of glycaemic control for women with gestational diabetes mellitus: tight glycaemic targets vs less‐tight glycaemic targets (child (as neonate, child, adult) outcomes) Neurosensory disability · children (as neonate, child, adult) of women with gestational diabetes mellitus Different intensities of glycaemic control for women with gestational diabetes mellitus (2023) · Cochrane | no estimate extracted | NR | No studies |
Intensity of glycaemic control for women with gestational diabetes mellitus: tight glycaemic targets vs less‐tight glycaemic targets (child (as neonate, child, adult) outcomes) Diabetes · children (as neonate, child, adult) of women with gestational diabetes mellitus Different intensities of glycaemic control for women with gestational diabetes mellitus (2023) · Cochrane | no estimate extracted | NR | No studies |
Intensity of glycaemic control for women with gestational diabetes mellitus: tight glycaemic targets vs less‐tight glycaemic targets (maternal outcomes) Subsequent development of type 2 diabetes · women with gestational diabetes mellitus Different intensities of glycaemic control for women with gestational diabetes mellitus (2023) · Cochrane | no estimate extracted | NR | No studies |
Intensity of glycaemic control for women with gestational diabetes mellitus: tight glycaemic targets vs less‐tight glycaemic targets (maternal outcomes) Return to pre‐pregnancy weight · women with gestational diabetes mellitus Different intensities of glycaemic control for women with gestational diabetes mellitus (2023) · Cochrane | no estimate extracted | NR | No studies |
Intensity of glycaemic control for women with gestational diabetes mellitus: tight glycaemic targets vs less‐tight glycaemic targets (maternal outcomes) Perineal trauma · women with gestational diabetes mellitus Different intensities of glycaemic control for women with gestational diabetes mellitus (2023) · Cochrane | no estimate extracted | NR | No studies |
Intensity of glycaemic control for women with gestational diabetes mellitus: tight glycaemic targets vs less‐tight glycaemic targets (maternal outcomes) Postnatal depression · women with gestational diabetes mellitus Different intensities of glycaemic control for women with gestational diabetes mellitus (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Support plus vs usual care Stopping breastfeeding (any) at 9 months ‐ not reported · healthy breastfeeding women with healthy term babies Support for healthy breastfeeding mothers with healthy term babies (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids vs single course Admission to the intensive care unit ‐ not reported · the woman Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health… (2022) · Cochrane | no estimate extracted | NR | No studies |